This company has been marked as potentially delisted and may not be actively trading. Champions Oncology (CSBR) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Champions Oncology (NASDAQ:CSBR)CurrentInstitutional OwnershipPercentage41.30%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$405.95KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$830.10K Get CSBR Insider Trade Alerts Want to know when executives and insiders are buying or selling Champions Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CSBR Institutional Buying and Selling by Quarter Champions Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025Northern Trust Corp53,994$463K0.0%+31.5%0.391% 2/13/2025Renaissance Technologies LLC138,839$1.19M0.0%+15.7%1.005% 2/12/2025Geode Capital Management LLC66,511$570K0.0%+2.2%0.481% 2/11/2025Virtu Financial LLC11,051$95K0.0%N/A0.080% 2/10/2025Tocqueville Asset Management L.P.608,915$5.22M0.1%-13.7%4.406% 11/15/2024HighTower Advisors LLC39,308$191K0.0%+14.6%0.289% 4/26/2024Mesirow Financial Investment Management Inc.12,380$61K0.0%N/A0.091% 2/13/2024Aristides Capital LLC11,822$66K0.0%-45.3%0.087% 2/8/2024Essex Investment Management Co. LLC77,200$434K0.1%-26.7%0.568% 11/9/2023Essex Investment Management Co. LLC105,335$654K0.1%-5.4%0.781% Get the Latest News and Ratings for CSBR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Champions Oncology and its competitors with MarketBeat's FREE daily newsletter. 5/15/2023 Overbrook Management Corp48,488$195K0.1%-10.0%0.358% 5/10/2023Tocqueville Asset Management L.P.665,428$2.68M0.1%+8.2%4.907% 2/9/2023Tocqueville Asset Management L.P.615,228$2.78M0.1%+80.1%4.537% 11/15/2022Essex Investment Management Co. LLC107,711$808K0.1%-6.4%0.797% 11/14/2022Ergoteles LLC13,937$105K0.0%N/A0.103% 10/31/2022Millrace Asset Group Inc.346,976$2.60M3.3%-2.0%2.566% 7/28/2022Millrace Asset Group Inc.354,041$2.83M2.7%+7.6%2.619% 5/9/2022Essex Investment Management Co. LLC115,075$936K0.1%+8.1%0.851% 2/10/2022Essex Investment Management Co. LLC106,423$890K0.1%+18.9%0.787% 2/3/2022ACT Capital Management LLC62,500$523K0.4%+6.8%0.462% 11/16/2021ACT Capital L.L.C.58,500$597K0.3%+17.0%0.436% 11/15/2021Dimensional Fund Advisors LP119,902$1.22M0.0%-8.2%0.893% 11/15/2021HighTower Advisors LLC26,467$270K0.0%+36.2%0.197% 11/12/2021Renaissance Technologies LLC221,146$2.26M0.0%-3.0%1.648% 11/9/2021Essex Investment Management Co. LLC89,507$914K0.1%-1.8%0.667% 11/9/2021BlackRock Inc.122,398$1.25M0.0%+14.4%0.912% 8/17/2021Millennium Management LLC88,310$908K0.0%N/A0.658% 8/16/2021State Street Corp24,163$248K0.0%-76.2%0.180% 8/13/2021Northern Trust Corp27,719$285K0.0%-68.8%0.207% 8/13/2021 Overbrook Management Corp94,940$976K0.2%-1.8%0.708% 8/13/2021Geode Capital Management LLC42,953$441K0.0%-53.7%0.320% 8/13/2021Vanguard Group Inc.327,636$3.37M0.0%-29.5%2.442% 8/12/2021Dimensional Fund Advisors LP130,655$1.34M0.0%+1.8%0.974% 8/12/2021JPMorgan Chase & Co.4,379$45K0.0%-78.4%0.033% 8/12/2021Bank of Montreal Can102,934$1.09M0.0%+39.1%0.767% 8/12/2021Ergoteles LLC30,900$318K0.0%N/A0.230% 8/11/2021Millrace Asset Group Inc.280,439$2.88M1.5%+7.8%2.090% 8/11/2021 Bank of New York Mellon Corp51,825$533K0.0%-24.1%0.386% 8/11/2021Susquehanna Fundamental Investments LLC28,382$292K0.0%N/A0.212% 7/31/2021Roubaix Capital LLC351,507$3.61M2.3%+25.9%2.621% The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a5/18/2021California State Teachers Retirement System9,731$110K0.0%-10.6%0.073% 5/17/2021Aristides Capital LLC36,750$415K0.2%-8.1%0.274% 5/14/2021Dimensional Fund Advisors LP128,293$1.45M0.0%-2.4%0.958% 5/13/2021ClariVest Asset Management LLC56,600$640K0.0%+5.6%0.423% 5/13/2021Barclays PLC5,658$64K0.0%+171.8%0.042% 5/13/2021Renaissance Technologies LLC228,433$2.58M0.0%+3.0%1.706% 5/13/2021Bank of Montreal Can74,012$842K0.0%-22.8%0.553% 5/12/2021Northern Trust Corp88,943$1.01M0.0%-17.1%0.664% 5/12/2021Millrace Asset Group Inc.260,082$2.94M1.6%+42.6%1.942% 5/12/2021JPMorgan Chase & Co.20,287$229K0.0%+7.8%0.152% 5/12/2021UBS Group AG2,553$29K0.0%+165.7%0.019% 5/11/2021Acadian Asset Management LLC31,477$356K0.0%+14.8%0.235% 5/10/2021HighTower Advisors LLC19,427$220K0.0%+17.0%0.145% 5/7/2021BlackRock Inc.470,447$5.32M0.0%+1.1%3.513% 4/29/2021Roubaix Capital LLC279,298$3.16M2.1%+35.3%2.086% 4/23/2021Strs Ohio31,500$355K0.0%-4.0%0.235% 3/8/2021Dimensional Fund Advisors LP131,513$1.42M0.0%-0.7%0.984% 2/25/2021Dimensional Fund Advisors LP131,513$1.42M0.0%-0.7%0.984% 2/19/2021JPMorgan Chase & Co.18,827$203K0.0%+69.0%0.141% (Data available from 1/1/2016 forward) CSBR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CSBR shares? During the previous two years, 10 institutional investors and hedge funds held shares of Champions Oncology. The most heavily invested institutionals were Tocqueville Asset Management L.P. ($5.22M), Renaissance Technologies LLC ($1.19M), Geode Capital Management LLC ($570K), Northern Trust Corp ($463K), Essex Investment Management Co. LLC ($434K), Overbrook Management Corp ($195K), and HighTower Advisors LLC ($191K).Learn more on CSBR's institutional investors. What percentage of Champions Oncology stock is owned by institutional investors? 41.30% of Champions Oncology stock is owned by institutional investors. Learn more on CSBR's institutional investor holdings. Which institutional investors have been buying Champions Oncology stock? The following institutional investors have purchased Champions Oncology stock in the last 24 months: Tocqueville Asset Management L.P. ($50.20K), Renaissance Technologies LLC ($18.85K), Northern Trust Corp ($12.92K), Mesirow Financial Investment Management Inc. ($12.38K), Virtu Financial LLC ($11.05K), HighTower Advisors LLC ($5K), and Geode Capital Management LLC ($1.45K). How much institutional buying is happening at Champions Oncology? Institutional investors have bought a total of 111,849 shares in the last 24 months. This purchase volume represents approximately $668.41K in transactions. Which Champions Oncology major shareholders have been selling company stock? The following institutional investors have sold Champions Oncology stock in the last 24 months: Tocqueville Asset Management L.P. ($96.30K), Essex Investment Management Co. LLC ($34.14K), Aristides Capital LLC ($9.80K), and Overbrook Management Corp ($5.40K). How much institutional selling is happening at Champions Oncology? Institutional investors have sold a total of 145,639 shares in the last 24 months. This volume of shares sold represents approximately $1.10M in transactions. Related Companies IMTX Institutional Ownership RLAY Institutional Ownership VALN Institutional Ownership OPT Institutional Ownership DNA Institutional Ownership RGNX Institutional Ownership CGEM Institutional Ownership MGTX Institutional Ownership TRML Institutional Ownership SANA Institutional Ownership This page (NASDAQ:CSBR) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Champions Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Champions Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.